Trump Administration Launches TrumpRx Website for Discounted Drugs

The Trump administration is introducing TrumpRx, a government-run website designed to help Americans find lower-cost prescription medications, with the launch scheduled for Thursday evening.

White House press secretary Karoline Leavitt announced that President Trump will present the new website alongside Dr. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, and Joe Gebbia, director of the National Design Studio.

According to information published by the White House, TrumpRx will not handle sales directly but will guide users to pharmaceutical companies’ direct-to-consumer platforms, where purchases can be completed.

Pfizer is participating in the TrumpRx initiative and is providing discounts on certain drugs, with price reductions ranging from approximately 50% to 85% off standard list prices.

What the numbers show

• TrumpRx launches on February 5, 2026
• Pfizer offers discounts between 50% and 85% on select drugs
• The initiative was first announced in September 2025

The TrumpRx program is part of a broader “Most-Favored-Nation” pricing approach, which aims to align U.S. drug prices with those found in other developed countries, according to information from GovFacts.

The website was initially announced in September 2025, with officials stating that the original launch was planned for early 2026 but experienced delays before the current rollout date was set.

TrumpRx is structured to serve as a referral platform, connecting users with pharmaceutical manufacturers that offer direct sales and discounts, rather than acting as a retailer itself.

This launch represents a procedural step in the administration’s ongoing efforts to address prescription drug costs through government-facilitated access and pricing strategies tied to international benchmarks.

* This article is based on publicly available information at the time of writing.